---
title: "Damora Therapeutics (DMRA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DMRA.US/norm.md"
symbol: "DMRA.US"
name: "Damora Therapeutics"
parent: "https://longbridge.com/en/quote/DMRA.US.md"
datetime: "2026-03-11T17:50:45.941Z"
locales:
  - [en](https://longbridge.com/en/quote/DMRA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DMRA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DMRA.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DMRA.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DMRA.US/norm.md)


# Damora Therapeutics (DMRA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.36 | -2.60 | -1.92 | -5.13 | -3.39 |
| ROE | -153.97% | -125.20% | -75.56% | -152.31% | -69.77% |
| Revenue | - | - | - | - | - |
| Net income | -3.13M | -3.44M | -2.53M | -6.74M | -3.88M |
| Operating income | -3.16M | -3.42M | -2.60M | -2.71M | -3.84M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 10.74M | 13.69M | 15.37M | 17.13M | 23.38M |
| Leverage | 1.34 | 1.25 | 1.12 | 1.08 | 1.12 |
| BVPS | 5.02 | 7.26 | 9.34 | 10.99 | 16.70 |
| Turnover | - | - | - | - | - |
| Cash & STI | 7.61M | 10.21M | 11.94M | 14.18M | 19.68M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 113000.00 | 122000.00 | 125000.00 | 130000.00 | 94000.00 |
| Net debt | -7.53M | -10.14M | -11.87M | -14.10M | -19.65M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.62M | -2.24M | -2.44M | -4.94M | -3.65M |
| Investing CF | - | - | - | 0.0000 | 0.0000 |
| Financing CF | - | - | - | - | - |
| Free CF | -1.17M | -713125.00 | -1.40M | -3.73M | -2.08M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |